DW Healthcare Partners, a healthcare-focused private equity firm, announced on February 3 the sale of LKC Technologies to Ametek, Inc. LKC Technologies will join Ametek as part of its Electronic Instruments Group.
LKC Technologies is a leading provider of technologies to enable the effective diagnosis and management of ophthalmic conditions. LKC Technologies develops portable devices that help doctors test and monitor eye health. These tools are designed to detect early signs of diabetic retinopathy and other serious eye conditions that can lead to vision loss. The company is headquartered in Germantown, Maryland. DW Healthcare Partners previously invested in LKC Technologies in June 2023.
Ametek, Inc. is a global provider of industrial technology solutions serving a diverse set of attractive niche markets with annual sales of approximately $7.5 billion. The company has approximately 22,500 colleagues across a global network of operating, sales, service and support locations in 34 countries around the world.
William Blair served as the exclusive financial advisor to LKC Technologies. Financial terms of the deal were not disclosed.
According to data captured in the LevinPro HC database, this marks the 14th Medical Device transaction of 2026. Other acquirers in the space this year include Nissha, BioStem Technologies, Boston Scientific, VB Spine, Solmetex and Smith+Nephew, Haemonetics. There were 86 Medical Device deals announced during 2025, 87 announced in 2024 and 112 announced during 2023.
